scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Neuland Laboratories Ltd

Feedback
Neuland Laboratories Ltd

Neuland Laboratories Ltd (NEULANDLAB) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 34,835
Mar 12, 2025 15:22 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹10,971.55
₹-182.75 (-1.53%)
₹10753 Low
Today’s Performance
₹11252 High
₹5540.1 Low
52 Week’s Performance
₹18100 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.53%
  • 1 Week -2.13%
  • 1 Month -18.39%
  • 3 Months -34.21%
  • 6 Months -11.51%
  • 1 Year 87.36%
  • 3 Years 109.52%
  • 5 Years 98.14%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.50
  • 52-Week Low (₹) 5,540.10
  • 52-Week High (₹) 18,100.00
  • Price-to-Book (X)* 10.27
  • Dividend Yield (%) 0.13
  • Price-to-Earnings (P/E) (X)* 47.77
  • Earnings Per Share (₹) 233.72
  • Sector Price Earning (X)* 32.47
  • Market Cap (₹ Cr.)* 14,310.84
  • * Vaues as of last close price

COMPETITORS

BT TV

Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today 46:53 Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today
CM Rekha Gupta: "Modi Ji Said CM’s Role Is For Work, Not Just Ceremonies" 2:34 CM Rekha Gupta: "Modi Ji Said CM’s Role Is For Work, Not Just Ceremonies"
Nirmala Sitharaman Slams DMK Over Tamil Language Controversy: ‘Look At Their Hypocrisy’ 0:48 Nirmala Sitharaman Slams DMK Over Tamil Language Controversy: ‘Look At Their Hypocrisy’
Jamie Dimon On AI impact: It Will Replace Jobs In Banking And Financial Services 4:30 Jamie Dimon on Private Equity’s Rise & Public Market Exodus | Stanford GSB Talk
Secure Your Portfolio With Top Market Guru Dhiraj Agarwal, MD, Ambit Investment Managers 32:50 Secure Your Portfolio With Top Market Guru Dhiraj Agarwal, MD, Ambit Investment Managers
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Jun 26, 2024 PURCHASE
SMALLCAP WORLD FUND INC
  • Qty 130000
  • Average Price ₹7,400.00
Jun 26, 2024 Sell
MALABAR INDIA FUND LIMITED
  • Qty 130000
  • Average Price ₹7,400.00
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jun 26, 2024 PURCHASE
SMALLCAP WORLD FUND INC
  • Qty 130000
  • Average Price ₹7,400.00
Jun 26, 2024 Sell
MALABAR INDIA FUND LIMITED
  • Qty 130000
  • Average Price ₹7,400.00
Aug 31, 2023 Sell
BNP PARIBAS ARBITRAGE
  • Qty 64893
  • Average Price ₹3,871.31
May 11, 2023 PURCHASE
NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 65827
  • Average Price ₹2,491.99
May 11, 2023 Sell
NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 65927
  • Average Price ₹2,493.34
Aug 06, 2021 Sell
CHARU S SHAH
  • Qty 80000
  • Average Price ₹1,633.28
Feb 09, 2021 PURCHASE
EMPLOYEES RETIREMENT SYSTEM OF TEXAS - SELF MANAGED PORTFOLIO
  • Qty 86000
  • Average Price ₹1,842.24
Feb 03, 2021 Sell
ROHINTON SOLI SCREWVALA
  • Qty 86170
  • Average Price ₹1,480.60
Jan 18, 2021 PURCHASE
RIKEEN P DALAL HUF
  • Qty 80000
  • Average Price ₹1,310.71
Nov 03, 2020 Sell
XTX MARKETS LLP
  • Qty 66605
  • Average Price ₹1,240.88
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Neuland Laboratories Ltd share price previously?
Neuland Laboratories Ltd share price was down by -1.53% from the previous closing price of ₹11,154.30.
Who are peers of Neuland Laboratories Ltd?
The peers of Neuland Laboratories Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Mankind Pharma Ltd, Zydus Lifesciences Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd,
Who is/are the promoter/promoters of Neuland Laboratories Ltd?
The promotor/promotors of Neuland Laboratories Ltd are D R Rao, Christopher M Cimarusti, D Sucheth Rao, D Saharsh Rao, Sarada Bhamidipati, Nirmala Murthy, Homi Rustam Khusrokhan, Prasad R Menon, Sugata Sircar, Pallavi Joshi Bakhru.
What has been 52-week high of Neuland Laboratories Ltd stocks?
The highest price of Neuland Laboratories Ltd stock is ₹18,100.00 in the last 52-week.
What is the share price of Neuland Laboratories Ltd (NEULANDLAB) today on NSE?
As on Mar 12, 2025, Neuland Laboratories Ltd (NEULANDLAB)’s share price on NSE is Rs 10971.55
What is the market cap of Neuland Laboratories Ltd (NEULANDLAB?)
The current market capitalisation of Neuland Laboratories Ltd (NEULANDLAB) is 14,310.84 crores
What is Neuland Laboratories Ltd Share symbol?
The symbol of Neuland Laboratories Ltd is NEULANDLAB.
What is the PE ratio of Neuland Laboratories Ltd (NEULANDLAB)?
The current PE ratio of Neuland Laboratories Ltd (NEULANDLAB) is 47.77.
What is the PB ratio of Neuland Laboratories Ltd (NEULANDLAB)?
The current PB ratio of Neuland Laboratories Ltd (NEULANDLAB) is 10.27.
Today’s High & Low share prices of Neuland Laboratories Ltd (NEULANDLAB) on NSE?
Today, the share price of Neuland Laboratories Ltd (NEULANDLAB) on NSE touched a high of Rs 11252 and a low of Rs 10753
What price did Neuland Laboratories Ltd (NEULANDLAB) shares open on the NSE today?
On NSE, the share price of Neuland Laboratories Ltd (NEULANDLAB) opened at Rs 11152
What is the 52-week high of Neuland Laboratories Ltd (NEULANDLAB)?
The 52-week high price of Neuland Laboratories Ltd (NEULANDLAB) is Rs 18100
What is the 52-week low of Neuland Laboratories Ltd (NEULANDLAB) ?
The 52-week low price of Neuland Laboratories Ltd (NEULANDLAB) is Rs 5540.1

ABOUT NEULAND LABS.

Neuland Laboratories Ltd, incorporated in the year 1984, has its registered office in 11 Th Floor Phoenix IVY Buildi, Plot No 573A-III Road No 82, Hyderabad, Telangana, 500035, 91-40-30211600, 91-40-30211602. The main industry in which Neuland Laboratories Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Neuland Laboratories Ltd is/are MSKA & Associates. In the main management, D Saharsh Rao is chairman and Sarada Bhamidipati is the company secretary for Neuland Laboratories Ltd.

  • DRR D R Rao Executive Chairman
  • CMC Christopher M Cimarusti Non Executive Director
  • DSR D Sucheth Rao Vice Chairman & CEO
  • DSR D Saharsh Rao Vice Chairman & M.D.
  • SB Sarada Bhamidipati Company Sec. & Compli. Officer
  • NM Nirmala Murthy Independent Director
  • HRK Homi Rustam Khusrokhan Independent Director
  • PRM Prasad R Menon Independent Director
  • SS Sugata Sircar Independent Director
  • PJB Pallavi Joshi Bakhru Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement